Company attributes
Industry
Location
Founder
Pitchbook URL
Legal Name
Immusoft Corporation
Number of Employees (Ranges)
11 – 50
Full Address
454 North 34th Street Seattle, WA 98103 United States
CIK Number
Investors
DUNS Number
831407775
Founded Date
2009
0Email Address
info@immusoft.com
Total Funding Amount (USD)
37,917,000
Latest Funding Round Date
September 2020
Latest Funding Type
Patents Assigned (Count)
3
Country
Other attributes
Company Operating Status
Active
Immusoft is developing an approach to sustained delivery of protein therapeutics using a patient's own cells. The approach is called Immune System Programming (ISPTM). ISP entails collecting a type of the patient's immune cells, called B cells. In response to immune stimulation, B cells can turn into a biofactory state known as a plasma cell. Plasma cells manufacture and secrete thousands of antibodies per second. We harness this biofactory capability of the plasma cell by programming B cells to produce a given protein therapeutics.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.